Skip to content

ViOph.arma

Active Private limited companyfounded 1996active for 30 yearsRue de l'Aisette 16, 7080 FrameriesKBO/BCE: BE 0457.301.055 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 30 filings since 1996
peak of €281,108 in 2023
€252,910▼ 2.8%
peak of €115,804 in 2022
€61,723▼ 12.9%
peak of €406,053 in 2025
€406,053▲ 1.7%
€283,382▲ 6.7%
peak of 2 FTE in 2025
2 FTE▲ 5.3%
Board5 names since 2014
2 directors and 1 other
Owners
100%
Documentsfilings and deeds
01-07-202630 days before the deadline
2025abbreviated format
Dividend €55,000

Key points

from the 2025 annual accounts

Equity

€406,053 ▲ 1.7%
399,3312024+61,723Profit-55,000Dividend406,0532025

ViOph.arma paid out €55,000 in dividends. That is 89% of the 2025 profit.

Turnover

≈ €870,000 estimated

The accounts state no turnover.

Staff

3 employees on 31-12-2025
102021102022212023232025

In 2025, 2 employees joined and 3 left.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as ViOph.arma has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for ViOph.arma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 100%equity €888,085 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0457301055
reappointed as director General meeting of 28-05-2020 · Gazette deed
Company renamed from Waviphar to ViOph.arma Capital increase of BEF 1,251,074 to BEF 2,501,074 · The capital rose from BEF 1,250,000 to BEF 2,501,074 · appointed as manager · Gazette deed
1 director appointed, 3 resignations (managing director), and resign · appointed as managing director · and act as permanent representatives · General meeting of 31-12-2014 · Gazette deed
All 41 events

Comparable companies

same main activity, similar in size and age
Company
ViOph.arma Frameries €689,435 €252,910 58.9% 2
PHARMACIE DU CAZIER Charleroi €713,919 €219,642 58.6% 2.5
SANTE SERVICES Mons €829,810 €251,051 22.6% 2.5
FARMAPUNT ACHEL Hamont-Achel €721,434 €291,653 60.5% 2
D'HUYVETTER - VANDERMARLIERE Zulte €737,810 €244,606 78.0% 1.7
NB PHARMA Nieuwpoort €745,538 €272,272 77.0% 1.8
APOTHEEK DECLERCK Kortrijk €790,903 €278,652 58.4% 2.1

These companies have the same main activity as ViOph.arma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €714,000 and €830,000, founded between 1996 and 2000.

Official details

Source: KBO
Status
Active since 20-02-1996Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.075.794.3577080 Frameries, since 25-03-1996
Financial year end
31 December
Peppol
Reachable since 22-12-2025
Company details

Annual accounts 2025

€689,435▲ 3.7%
Employeeson 31-12-2025
3▼ 25.0%
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on ViOph.arma

ViOph.arma files the abbreviated format. That format states no turnover. The gross margin rose from €86,290 in 2006 to €252,910 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ViOph.arma

What is the company number of ViOph.arma?
The company number of ViOph.arma is 0457.301.055. The VAT number is the same number with BE in front: BE 0457.301.055.
Where is ViOph.arma based?
The registered office is at Rue de l'Aisette 16, 7080 Frameries.Company details
What does ViOph.arma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of ViOph.arma?
ViOph.arma is a private limited company (BV).
When was ViOph.arma founded?
ViOph.arma was founded on 20-02-1996.
Is ViOph.arma still active?
Yes, ViOph.arma is an active enterprise in the KBO register.
How many employees does ViOph.arma have?
ViOph.arma had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does ViOph.arma fall under?
In its 2025 annual accounts, ViOph.arma states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of ViOph.arma?
The turnover in financial year 2025 is about €870,000. This figure is estimated from the gross margin of €252,910 and 42 comparable companies (NACE 477). It probably lies between €690,000 and €1.2m.
Is ViOph.arma profitable?
In financial year 2025, ViOph.arma made a profit of €61,723.
Where can I find the annual accounts of ViOph.arma?
ViOph.arma filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ViOph.arma due?
ViOph.arma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.